33.44 - 34.57
31.40 - 61.90
7.61M / 5.95M (Avg.)
-152.73 | -0.22
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
7.25%
Revenue growth under 50% of TOST's 15.93%. Michael Burry would suspect a deteriorating sales pipeline or weaker brand.
8.43%
Gross profit growth at 50-75% of TOST's 13.29%. Martin Whitman would question if cost structure or brand is lagging.
18.60%
EBIT growth below 50% of TOST's 62.00%. Michael Burry would suspect deeper competitive or cost structure issues.
18.60%
Operating income growth under 50% of TOST's 86.05%. Michael Burry would be concerned about deeper cost or sales issues.
23.79%
Net income growth at 50-75% of TOST's 42.86%. Martin Whitman would question fundamental disadvantages in expenses or demand.
312.05%
EPS growth above 1.5x TOST's 47.37%. David Dodd would review if superior product economics or effective buybacks drive the outperformance.
312.05%
Diluted EPS growth above 1.5x TOST's 47.90%. David Dodd would see if there's a robust moat protecting these shareholder gains.
0.92%
Share count expansion well above TOST's 0.87%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
0.92%
Diluted share count expanding well above TOST's 0.33%. Michael Burry would fear significant dilution to existing owners' stakes.
No Data
No Data available this quarter, please select a different quarter.
98.78%
OCF growth at 50-75% of TOST's 182.28%. Martin Whitman would question if the firm lags in monetizing sales effectively.
138.00%
FCF growth 50-75% of TOST's 201.45%. Martin Whitman would see if structural disadvantages exist in generating free cash.
24.90%
10Y revenue/share CAGR under 50% of TOST's 748.84%. Michael Burry would suspect a lasting competitive disadvantage.
24.90%
5Y revenue/share CAGR under 50% of TOST's 748.84%. Michael Burry would suspect a significant competitive gap or product weakness.
24.90%
3Y revenue/share CAGR under 50% of TOST's 101.73%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
138.54%
10Y OCF/share CAGR under 50% of TOST's 462.54%. Michael Burry would worry about a persistent underperformance in cash creation.
138.54%
Below 50% of TOST's 462.54%. Michael Burry would be alarmed about sustained underperformance in generating free operational cash.
138.54%
3Y OCF/share CAGR under 50% of TOST's 1032.89%. Michael Burry would worry about a significant short-term disadvantage in generating operational cash.
48.55%
Below 50% of TOST's 218.41%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
48.55%
Below 50% of TOST's 218.41%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
48.55%
Below 50% of TOST's 880.89%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
170.11%
Equity/share CAGR of 170.11% while TOST is zero. Bruce Berkowitz might see a slight advantage that can compound significantly over 10 years.
170.11%
Equity/share CAGR of 170.11% while TOST is zero. Bruce Berkowitz might see a minor advantage that could compound if the firm maintains positive net worth growth.
170.11%
3Y equity/share CAGR above 1.5x TOST's 38.88%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-0.04%
Firm’s AR is declining while TOST shows 2.54%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
1.92%
We show growth while TOST is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
2.07%
Asset growth well under 50% of TOST's 7.92%. Michael Burry sees the competitor as far more aggressive in building resources or capacity.
2.63%
Under 50% of TOST's 7.73%. Michael Burry raises concerns about the firm’s ability to build intrinsic value relative to its rival.
-1.99%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
0.67%
R&D dropping or stable vs. TOST's 8.33%. David Dodd sees near-term margin benefits if the product pipeline is already strong.
2.00%
SG&A growth well above TOST's 3.77%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.